NASDAQ:AERI
Delisted
Aerie Pharmaceuticals Stock News
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
07:30am, Tuesday, 27'th Oct 2020
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies f
Next Generation Cancer Diagnostics: Technologies and Global Markets (2019-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 25'th Aug 2020
The
New Strong Sell Stocks for August 10th
02:01pm, Monday, 10'th Aug 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Aerie (AERI) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
02:53pm, Friday, 07'th Aug 2020
Aerie (AERI) posts a wider-than-expected loss and sales miss estimates in the second quarter of 2020.
Aerie Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
08:01pm, Thursday, 06'th Aug 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Analysts Anticipate Aerie Pharmaceuticals Inc (NASDAQ:AERI) to Announce -$0.79 Earnings Per Share
07:28am, Wednesday, 05'th Aug 2020
Analysts predict that Aerie Pharmaceuticals Inc (NASDAQ:AERI) will post ($0.79) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided e
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Short Interest Update
03:46am, Tuesday, 04'th Aug 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) saw a large drop in short interest in July. As of July 15th, there was short interest totalling 8,050,000 shares, a drop of 10.6% from the June 30th total of 9,
Aerie Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020
11:30am, Thursday, 30'th Jul 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Will Aerie Pharmaceuticals (AERI) Report Negative Q2 Earnings? What You Should Know
04:33pm, Wednesday, 29'th Jul 2020
Aerie (AERI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celsion Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
03:53pm, Tuesday, 28'th Jul 2020
Celsion advances Phase II advanced ovarian cancer trial. Zentalis inks clinical collaboration with Eli Lilly.
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Contrasting Aerie Pharmaceuticals (NASDAQ:AERI) & Seattle Genetics (NASDAQ:SGEN)
01:20am, Sunday, 19'th Jul 2020
Aerie Pharmaceuticals (NASDAQ:AERI) and Seattle Genetics (NASDAQ:SGEN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their
Did Hedge Funds Make The Right Call On Aerie Pharmaceuticals Inc (AERI) ?
06:06pm, Friday, 17'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Parametric Portfolio Associates LLC Lowers Stock Position in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
04:28am, Sunday, 05'th Jul 2020
Parametric Portfolio Associates LLC reduced its stake in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 64.6% during the first quarter, according to the company in its most recent 13F filing wit